Showing results (1651-1660 of 1,853) with videos related to

Sort By:
Pageof 186
The Lancet. Oncology|December 8, 2015
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trialShuichi Hironaka, Naotoshi Sugimoto, Kensei Yamaguchi, et al.
Plant Physiology|March 18, 2022
Tracking metabolites at single-cell resolution reveals metabolic dynamics during plant mitosisEmiko Okubo-Kurihara, Ahmed Ali, Mika Hiramoto, et al.
ESMO Open|December 5, 2019
Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancerToshiki Masuishi, Hiroya Taniguchi, Daisuke Kotani, et al.
Biochemical and Biophysical Research Communications|December 21, 2004
Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitorShojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, et al.
Psychiatry and Clinical Neurosciences|August 6, 2025
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational StudyRyoichi Sadahiro, Katsuya Ohbuchi, Taiki Nakaya, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2017
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancerAkitaka Makiyama, Kohei Arimizu, Gen Hirano, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 5, 2016
Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)A Tsuburaya, N Sugimoto, H Imamura, et al.
Emerging Infectious Diseases|August 6, 2024
Cocirculation of Genetically Distinct Highly Pathogenic Avian Influenza H5N5 and H5N1 Viruses in Crows, Hokkaido, JapanYik Lim Hew, Takahiro Hiono, Isabella Monne, et al.
JCO Precision Oncology|January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH TrialMitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Pageof 186